Delivery Order SPE2DR25D1100-SPE2DR26FCS4Z
- Not listed
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $46,395.18 for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed price contract. This non-competitive delivery order, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $29,602.52 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price, competitively awarded contract is not set-aside and carries an ultimate completion date of August 12, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through...
- The Defense Logistics Agency awarded a $3,619.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award supports the company's role as a prime pharmaceutical vendor...
- The Defense Logistics Agency awarded a $7,397.89 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on September 22, 2025, with completion targeted for September 23, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $21.2K to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on May 30, 2025, with completion targeted for June 2, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $1B ceiling value and extends through December 2026. The pharmaceutical distributor will perform...
- The Defense Logistics Agency awarded a delivery order valued at $13,485.90 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on October 20, 2025, with completion targeted for October 21, 2025. This competitive award, issued under a firm fixed-price delivery order contract with no set-aside designation, represents a pharmaceutical supply delivery to be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The order is a child action under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,605.35 on August 20, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $30,275.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed...
- The Defense Logistics Agency awarded a $12,578.87 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 28, 2025, with completion required by July 29, 2025. This is a firm fixed price, non-set-aside contract with performance location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS4ZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35.7K to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for military healthcare programs worldwide. The award demonstrates AmerisourceBergen's continued role as a critical pharmaceutical distributor within the federal medical supply chain, delivering specialty medications and branded pharmaceuticals to support Defense Health Agency and other government healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider with an extensive portfolio of federal contract awards predominantly issued through competitive procurement processes. The company's federal business encompasses delivery of a wide range of pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for RINVOQ ER, a specialty pharmaceutical product, reflects AmerisourceBergen's capability to fulfill federal medical procurement requirements through open competition and supports the company's established position as a prime vendor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 12/1/25 |